Ipsen at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Ipsen takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover business development in a shifting global landscape and a survey of the therapeutic landscape informed by analyst research. Ipsen also sponsors the meeting.

OrganizationBIO-Europe 2026 Attendance
Ipsen
Boulogne-Billancourt, France
◆Platinum Sponsor
Large pharmaPlatinum sponsor
French global biopharmaceutical company focused on oncology, rare diseases and neuroscience.
Panel
Mon Nov 9
13:00–14:00
Navigating partnering and business development in a shifting global landscape
How funding conditions, treatment trends and geopolitics are shaping partnerships and acquisitions between drug and biotech companies, with real deal examples.
with Syneos Health, Abingworth, Genmab +2 more
Panel
Mon Nov 9
13:00–13:45
The therapeutic landscape backed by analyst insights
Which disease areas analysts rate most promising for new drugs and investment, and how new science and rule changes are reshaping them.
with Thuja Capital, Medicxi, AlphaSense

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ipsen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction